The ticker symbol is DAVI.
Davion Healthcare Plc is listed on the NASDAQ Global Market.
October 22, 2026
There are currently 25,000,000 Ordinary Shares in issue.
No. The company does not currently pay dividends, with earnings reinvested to fund growth.
Headquartered in Cork, Ireland, with additional operations in Miami, U.S.
Davion Healthcare Plc is a next-generation digital healthcare company developing proprietary, non-invasive health monitoring technologies for the early detection of medical anomalies. Its flagship product, BreastCheck, is an FDA-registered at-home breast monitoring device. Davion is expanding its healthcare portfolio and commercial capabilities through continued product development and strategic acquisitions.
Davion develops and protects its proprietary technologies, bringing them to market through two complementary routes: licensing to international distribution partners, generating royalties, and direct distribution through acquired and integrated businesses. The Company pursues strategic acquisitions to expand its product portfolio, operating capabilities and commercial reach.
Fiscal quarters follow the calendar year (March, June, September, December).
Through the Investor Relations page at contact us page or by email at investor@davionhealthcare.com.